<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ABC</journal-id><journal-title-group><journal-title>Advances in Biological Chemistry</journal-title></journal-title-group><issn pub-type="epub">2162-2183</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/abc.2014.44033</article-id><article-id pub-id-type="publisher-id">ABC-47311</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>CHEMISTRY &amp; MATERIALS SCIENCE</subject></subj-group></article-categories><title-group><article-title>Bio-Medical Aspects of Purine Alkaloids</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Milan</surname><given-names>Melnik</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ondrej</surname><given-names>Sprusansky</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Peter</surname><given-names>Musil</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University, Bratislava, Slovak Republic</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>qmelnik@stuba.sk(MM)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>06</month><year>2014</year></pub-date><volume>04</volume><issue>04</issue><fpage>274</fpage><lpage>280</lpage><history><date date-type="received"><day>1</day>	<month>May</month>	<year>2014</year></date><date date-type="rev-recd"><day>1</day>	<month>June</month>	<year>2014</year>	</date><date date-type="accepted"><day>28</day>	<month>June</month>	<year>2014</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>This review shortly summarized bio-medical activities of purine alkaloids, caffeine (caf), theophyline (top) and theobromine (tob). Caffeine potentiates the cytotoxicity of a variety of DNA domaging agents. Caffeine increased antitumor activity of some cancerostatic drugs. Caffeine inhibits the carcinogenic activity of cigarette smoke, significantly potentiating the therapeutic effect of acetaminophenol, cyclophosphoramide, enhances lipid oxidation, affects the central nervous system and alters cardiovascular system. Theophyline has expressive anti-inflammatory and antiasthmatic effect, and enhanced mobilization of lipid reduces the brain regional adenylate cyclase activity, facilitates glucose inhibition. Theophyline is muscle relaxant, vasodilator, diuretic and cardiac stimulant. Theobromine increases antitumor activity of adriamycin and doxorubicin, has expressive anti-inflammatory effect and it is classical diureticum. Several examples of caffeine with some organic substrates as well as with copper are also outlined. Increasing activity of the respective drugs in the present of the purine alkaloids can be ascribed to direct interaction as was proved by X-ray data of some caffeine adducts with organic substances as well as Cu(II) complexes.</p></abstract><kwd-group><kwd>Bio-Medical Activity</kwd><kwd> Caffeine</kwd><kwd> Purine Alkaloids</kwd><kwd> Theophyline</kwd><kwd> Theobromine</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Alkaloids are most fascinating organic compounds and many researches pay great attention to them. Purine alkaloids are chosen from the wide range of alkaloids. Purine alkaloids, caffeine, theophyline and theobromine are well known and daily consuming by man. The purine alkaloids possess pharmacological properties as therapeutic agents with a wide variety of activity. In spite of the fact, that from the structural point of view: caffeine (1,3, 7-trimethylxantine), theophyline (1,3-dimethylxantine) and theobromine (3,7-dimethylxantine) are very similar, their bio-medical activities are differing, for example, diuretic effect increases in the order: caffeine &lt; theophyline &lt; theobromine but in the same order the effects on CNS rapidly decrease. A thorough understanding of the geometric and electronic structure of the alkaloids is clearly essential in efforts to clucinadate receptor structure and function on design new pharmaceuticals (Scheme 1).</p><p>The reason of the improving bio-medical activity of drugs in the present of the purine alkaloids will be discussed.</p></sec><sec id="s2"><title>2. Bio-Effect of Purine Alkaloids</title><sec id="s2_1"><title>2.1. Activity of Caffeine (Caf)</title><p>Caffeine may be enhancing the tumoricidal effect of anticancer drugs, resp. DNA—damaging agents and possibly may aid in overcoming natural drug resistance [<xref ref-type="bibr" rid="scirp.47311-ref1">1</xref>] . An ionizing radiation and alkylating agents to potentiate the cytotoxic effects of caf on DNA damage agents [<xref ref-type="bibr" rid="scirp.47311-ref2">2</xref>] . Shoyab [<xref ref-type="bibr" rid="scirp.47311-ref3">3</xref>] proposed that the antitumorigenic effect of caffeine may be related to its ability to inhibit the bonding of active metabolites of carcinogens to cellular DNA. Traganos et al. [<xref ref-type="bibr" rid="scirp.47311-ref4">4</xref>] potentiate the cytotoxicity of a variety of DNA damaging agents presumable by reducing the ability of the cells to repair potentially lethal lesions and may pay a more general role to protecting cells against planar aromatic molecules such as intercalating agents. Therefore caffeine may be considered in designing strategies to modulate the activity of the intercalating drugs in vivo, e.g. in lowering drug toxicity when inadvertently applied at too bright doses [<xref ref-type="bibr" rid="scirp.47311-ref5">5</xref>] . The combination of caffeine with adriamycin can significantly increase the in vivo antitumor activity of this agent without increasing its side effect [<xref ref-type="bibr" rid="scirp.47311-ref6">6</xref>] . The effect of caffeine on adriamycin concentration in the cell plays an important role in the mechanism by which caffeine enhances adriamycin antitumor activity [<xref ref-type="bibr" rid="scirp.47311-ref7">7</xref>] . Also acts as a biochemical modulator of adriamycin [<xref ref-type="bibr" rid="scirp.47311-ref8">8</xref>] . The combination of adriamycin, cis- Pt(NH<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, and caffeine shoved partial response, and caffeine did not increase the vide effect of anticancer drugs [<xref ref-type="bibr" rid="scirp.47311-ref9">9</xref>] . Caffeine reduced the inhibitory effect of pirarubicin on the incorporation of thymine into DNA and uridine into RNA in cells [<xref ref-type="bibr" rid="scirp.47311-ref10">10</xref>] . Inhibit post replication repair of both UV and chemically induced damage in DNA lesions caused by cis-Pt(NH<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> [<xref ref-type="bibr" rid="scirp.47311-ref11">11</xref>] . Induction of DNA fragmentation during G2+M phase by caffeine modulates the cytotoxicity of cis-Pt(NH<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> in human osteosarcomic cells (strain) and the antitumor effect of cis-paltinum on transplanted osteosarcoma in athymic since [<xref ref-type="bibr" rid="scirp.47311-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.47311-ref13">13</xref>] . Caffeine enhanced the antitumor activity of doxorubicin with increasing doxorubicin concentration in tumors in vivo [<xref ref-type="bibr" rid="scirp.47311-ref14">14</xref>]. Caffeine is an inhibitor of DNA repair [<xref ref-type="bibr" rid="scirp.47311-ref15">15</xref>] . Caffeine inhibited the carcinogenic action of cigarette smoke condensate fraction before application [<xref ref-type="bibr" rid="scirp.47311-ref16">16</xref>] . The concomitant consumption of caffeine and cigarette constitutes a higher risk for the developing fetus [<xref ref-type="bibr" rid="scirp.47311-ref17">17</xref>] . Caffeine also potentiates the activity of cyclophosphamide [<xref ref-type="bibr" rid="scirp.47311-ref18">18</xref>] . Caffeine decreased the paracetamol induced hepatic toxicity [<xref ref-type="bibr" rid="scirp.47311-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.47311-ref20">20</xref>] . Caffeine significantly potentiates the therapeutic potential of acetaminophenol in man [<xref ref-type="bibr" rid="scirp.47311-ref21">21</xref>] . Anderson et al. [<xref ref-type="bibr" rid="scirp.47311-ref22">22</xref>] found that caffeine increases plasma epinephrine, cold increases oxygen consumption and carbohydrate metabolism, while decreasing lipid metabolism, Nishiyama et al. [<xref ref-type="bibr" rid="scirp.47311-ref23">23</xref>] found that caffeine also induced enhanced lipid oxidation as show by the significantly lower respiratory gas exchange ratio and increases in diastolic blood pressure during exercise. The results showed that caffeinated beverages have a potential to be useful supplements to the prescription of exercise for individuals who experience a depressed activity of the autonomic nervous system. Caffeine affects the central nervous system to binding to adenosine receptors, and it has acute and chronic dose dependent, effects on brain fraction [<xref ref-type="bibr" rid="scirp.47311-ref24">24</xref>] . Caffeine also showed the rate of compensatory sleep after sleep deprivation, as indexed by the duration of sleep states and sleep continuity [<xref ref-type="bibr" rid="scirp.47311-ref25">25</xref>] . Caffeine also alters cardiovascular dynamics by augmenting arterial blood pressure [<xref ref-type="bibr" rid="scirp.47311-ref26">26</xref>] . The secretary effect of caffeine may be mainly due to mobilization of calcium from an intracellular calcium pool [<xref ref-type="bibr" rid="scirp.47311-ref27">27</xref>] . High caffeine intake may predispose to cortical bone loss from the proximal femur [<xref ref-type="bibr" rid="scirp.47311-ref28">28</xref>] . Kawaga et al. [<xref ref-type="bibr" rid="scirp.47311-ref29">29</xref>] found, that caffeine facilitates the conversion of allopurinol to oxopurinol and produces high plasma level of oxopurinol in man. Valdes et al. [<xref ref-type="bibr" rid="scirp.47311-ref30">30</xref>] found that when caffeine intake during the gestational and lactation period by their</p><disp-formula id="scirp.47311-formula16"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://file.scirp.org/Html/htmlimages\7-1350207x\b937bffc-1cec-424e-bddb-886ed06fa5b0.png"/></disp-formula><p>Scheme 1. Structure of purine alkaloids.</p><p>dams and the growing period of pups affect the maxillary components of their offspring. The stimulating action of caffeine depends on the level and source of arousal [<xref ref-type="bibr" rid="scirp.47311-ref31">31</xref>] .</p></sec><sec id="s2_2"><title>2.2. Activity of Theophyline (Top)</title><p>Biological activity of theophyline also covers wide variety and will be shortly resented. Ito et al. [<xref ref-type="bibr" rid="scirp.47311-ref32">32</xref>] found that the low dose of theophyline exerts an anti-asthma effect through increasing activation of HDAC which is subsequently recruited by corticosteroids to suppress inflammatory genes. Sagara et al. [<xref ref-type="bibr" rid="scirp.47311-ref33">33</xref>] also confirmed that top has anti-inflammatory activity which is pertinent to the treatment of bronchial asthma, when is added to bronchodilator actions. Top decreases the natural sputum eosinophyl chemolactic activity present in asthmatic [<xref ref-type="bibr" rid="scirp.47311-ref34">34</xref>] . Taheuchi et al. [<xref ref-type="bibr" rid="scirp.47311-ref35">35</xref>] found that top is able to induce apoptosis of the IL-3-activated eosinoplies in patient with bronchial asthma, and that its clinical effectiveness may be due to the reduction of inflammatory cells in the airway. Small dose of top inhibited platelet-activating factor receptor mRNA expression in asthma blood lymphatic cells [<xref ref-type="bibr" rid="scirp.47311-ref36">36</xref>] . Changquan et al. [<xref ref-type="bibr" rid="scirp.47311-ref37">37</xref>] used top as therapeutic agent for the treatment of asthma. Pediatric asthma can be treatment by top even at low concentration [<xref ref-type="bibr" rid="scirp.47311-ref37">37</xref>] . Top suppresses that production of proinflammatory cytokines via inhibitor of NF-κB activation through protection of the IB protein [<xref ref-type="bibr" rid="scirp.47311-ref38">38</xref>] . Top treatment caused a significant increase in renal and muscle carnitine palmitoyltransferase activity [<xref ref-type="bibr" rid="scirp.47311-ref39">39</xref>] [<xref ref-type="bibr" rid="scirp.47311-ref40">40</xref>] . Top also enhanced mobilization of lipid from adipose tissues, which consequently stimulated an increased carnitine transport into the kidney tissues to from fatty acyl-carnitine groups for subsequent oxidation inside the mitochondria [<xref ref-type="bibr" rid="scirp.47311-ref41">41</xref>] . Oral top administration (100 mg/kg/day) changes the levels of carnitine in plasma and tissues and increases the activity of carnitine acetyltransferase in the cardiac tissues of rats [<xref ref-type="bibr" rid="scirp.47311-ref42">42</xref>] .</p><p>Mandal and Poddar found [<xref ref-type="bibr" rid="scirp.47311-ref43">43</xref>] that top under no tolerant condition produced region specific inhibition of adenylate cyclase activity and hence central adenosynergic activity which may be a resultant effect of heterogeneous distribution of extra cellular adenosine receptor (A1 and A2) of different brain regions and also the availability of adenosine for interaction to the intracellular receptor sites (P-site) under this condition. Development of tolerance to top may reduce the brain regional adenylate cyclase activity by increasing the A1 receptor population and hence may stimulate the central adenosynergic activity. Effects of xantine derivatives on phosphatydylcholine secretion in rat were studied by Omura et al. [<xref ref-type="bibr" rid="scirp.47311-ref44">44</xref>] . Top increased the PC secretion the Co-culture of type II pneumocytes and activated eosinophils through the inhibition of phosphodiesterases of the antagonism of adenosine reduced AMP stimulation and facilitated glucose inhibition [<xref ref-type="bibr" rid="scirp.47311-ref45">45</xref>] . Long term top treatment may potentiate or suppress the immune response, depending on the dose, through the tissue (liver/spleen/thymus) specific modulation of adenosine deaminase activity and plasma corticosterone status [<xref ref-type="bibr" rid="scirp.47311-ref46">46</xref>] . Top therapy at optimal doses my not exert adverse side effects on bone homeostasis, but patients receiving supratherapeutic doses of top should be under close exams, in order to periodic future bone mass status [<xref ref-type="bibr" rid="scirp.47311-ref47">47</xref>] Heparin and top in the medium are effective in activating metabolic enzymes, maintaining longer sperm mobility, and efficiently inducing hyper activated sperm even of the sperm of asthenozoospermia [<xref ref-type="bibr" rid="scirp.47311-ref48">48</xref>]</p><p>Top increased serum glucocorticoid levels in a dose-dependent manner [<xref ref-type="bibr" rid="scirp.47311-ref49">49</xref>] top used as a muscle relaxant or vasodilator [<xref ref-type="bibr" rid="scirp.47311-ref50">50</xref>] . Top is also effective as a diuretic and cardiac stimulant [<xref ref-type="bibr" rid="scirp.47311-ref51">51</xref>] . Top has a high ulcer score, increase the development of dental caries and this effect may be related to organism, alternation of salivary components [<xref ref-type="bibr" rid="scirp.47311-ref52">52</xref>] .</p></sec><sec id="s2_3"><title>2.3. Activity of Theobromine (Tob)</title><p>Tob inhibited adriamycin efflux in vitro, increased the antitumor activity of adriamycin and the concentration of adriamycin in tumors [<xref ref-type="bibr" rid="scirp.47311-ref8">8</xref>] . Tob increased the concentration of adriamycin in the tumor without any effects on that in the heart and the liver [<xref ref-type="bibr" rid="scirp.47311-ref53">53</xref>] . Tob inhibited the doxorubicin efflux from tumor cells, increased the doxorubicin concentration in a tumor, and enhanced the antitumor effect of doxorubicin [<xref ref-type="bibr" rid="scirp.47311-ref54">54</xref>] . Tob greatly suppressed urethane-induced tumorigenesis and teratogenesis, whereas top did not [<xref ref-type="bibr" rid="scirp.47311-ref55">55</xref>] . Tob as well as top produced high antiinflammatory activity against acute inflamation induced by acetic acid while caf showed no significant effect [<xref ref-type="bibr" rid="scirp.47311-ref56">56</xref>] . Tob and caf differentiated normally developing somniferous cords made up of Sertoli and germ cells, soon followed by the differentiation of functionally active Leyding cells appearing in the newly formed interstitum [<xref ref-type="bibr" rid="scirp.47311-ref57">57</xref>] . The ratio of tob/caf has effect on hepatic human flavin monooxygenase 3 activity [<xref ref-type="bibr" rid="scirp.47311-ref58">58</xref>] . Tob significantly increased the mouse’s ambulatory activity [<xref ref-type="bibr" rid="scirp.47311-ref59">59</xref>] .</p></sec></sec><sec id="s3"><title>3. Interactions of Caffeine with Copper</title><p>It is well known, that caffeine possessing pharmacological behaviors as a therapeutic agent with analeptic activity. Several crystal structures of caffeine with organic substrates have been determined, 5-chlorosalicylic acid [<xref ref-type="bibr" rid="scirp.47311-ref60">60</xref>] , barbital [<xref ref-type="bibr" rid="scirp.47311-ref61">61</xref>] [<xref ref-type="bibr" rid="scirp.47311-ref62">62</xref>] and also the hydrochloridedihydrate [<xref ref-type="bibr" rid="scirp.47311-ref63">63</xref>] . A few crystal structures of copper (II) complexes with caffeine have been also described. In two examples triaqua (caffeine) nitratocopper (II) nitrate [<xref ref-type="bibr" rid="scirp.47311-ref64">64</xref>] and aqua (caffeine) dichlorocopper (II) [<xref ref-type="bibr" rid="scirp.47311-ref65">65</xref>] , the copper(II) atoms are five coordinated. In our lab was prepared di (caffeine) tetrakis (naproxenato) dicopper (II) complex [<xref ref-type="bibr" rid="scirp.47311-ref66">66</xref>] . The compound is binuclear with square pyramidal geometry at each copper(II) centre. Similar binuclear structure of di (caffeine) tetrakis (2-bromopropionato) dicopper (II) [<xref ref-type="bibr" rid="scirp.47311-ref67">67</xref>] as those in [<xref ref-type="bibr" rid="scirp.47311-ref66">66</xref>] was obtained. In copper(II) complexes the caffeine directly coordinated to Cu(II) atom via N donor atom.</p><p>It was found [<xref ref-type="bibr" rid="scirp.47311-ref68">68</xref>] that the copper(II) carboxylates and their caffeine adducts exhibit considerable biological activity especially against bacteria G<sup>+ </sup>(S. aureus) than that against bacteria G<sup>&#175;</sup> (E. coli). The complexes have also caused an increase of inhibition activity against model fungi [<xref ref-type="bibr" rid="scirp.47311-ref69">69</xref>] . For the purpose indicating mechanism of action of Cu(2-MeSnic)<sub>2</sub>(nia)<sub>2</sub>(H<sub>2</sub>O)<sub>2</sub> with biosynthesis of nucleic acids and proteins has been monitored [<xref ref-type="bibr" rid="scirp.47311-ref67">67</xref>] . Effect of copper(II) carboxylates and their caffeine adducts on glycolysis respiration processes and cell membranes of the Ehrlich ascite carcinoma are in progress now.</p></sec><sec id="s4"><title>4. Conclusions</title><p>This review shortly summarized bio-medical activities of purine alkaloids. Caf potentiates the cytotoxicity of a variety of DNA damaging agents. The carcinogenic activity of cigarette smoke was inhibited. The cytotoxicity of some cancerostatic drugs, for example, cisplatin, pirarubicin, adriamycin, was enhanced. Caf decreases the paracetamol-induced hepatic toxicity, significantly potentiating the therapeutic effect of acetaminophenol, cyclophosphoamide, enhances lipid oxidation, affects the central nervous system and also alters cardiovascular system.</p><p>Top has expressive anti-inflammatory and anti-asthmatic effect, enhances mobilization of lipid, has an influence on the levels of carnitine in plasma, reduces the brain regional adenylate cyclase activity, participates glucose inhibition and suppresses the immune response. Top increases serum glucocorticoide level, is muscle relaxant, vasodilator, diuretic and cardiac stimulant, and has high ulcer score and development of dental caries.</p><p>Tob increases antitumor activity of adriamycin and doxorubicin, and suppresses urethane. It is classical diuretic and expressive anti-inflammatory effect. Bio-medical activity of the respective drugs in the present of the purine alkaloids can be ascribed to the direct interaction between the drugs and the alkaloids via the N-donor atom.</p></sec><sec id="s5"><title>Acknowledgements</title><p>The authors wish to thanks to OPRaD funded by the ERDF (ITMS 26240220071) for financial support.</p></sec></body><back><ref-list><title>References</title><ref id="scirp.47311-ref1"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>TOMITA</surname><given-names> K. </given-names></name>,<name name-style="western"><surname> TSUCHIJA</surname><given-names> H. </given-names></name>,<etal>et al</etal>. (<year>1989</year>)<article-title>CAFFEINE ENHANCEMENT OF THE EFFECT OF ANTICANCER AGENTS ON HUMAN SARCOMA CELLS</article-title><source>. CANCER SCIENCE</source><volume> 80</volume>,<fpage> 83</fpage>-<lpage>88</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1111/J.1349-7006.1989.TB02249.X</pub-id></mixed-citation></ref><ref id="scirp.47311-ref2"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>TRAGANOS</surname><given-names> F.</given-names></name>,<name name-style="western"><surname> KAPUCINSKI</surname><given-names> J.</given-names></name>,<name name-style="western"><surname> GONG</surname><given-names> J.</given-names></name>,<name name-style="western"><surname> ARDELT</surname><given-names> B. </given-names></name>,<name name-style="western"><surname> DARZYNKIEWICZ</surname><given-names> R.J. </given-names></name>,<etal>et al</etal>. (1993)<article-title>TRAGANOS, F., KAPUCINSKI, J., GONG, J., ARDELT, B. AND DARZYNKIEWICZ, R.J.  CAFFEINE PREVENTS APOPTOSIS AND CELL CYCLE EFFECTS INDUCED BY CAMPTOTHECIN OR TOPOTECAN IN HL-60 CELLS</article-title><source>. CANCER RESEARCH</source><volume> 53</volume>,<fpage> 4613</fpage>-<lpage>4618</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.47311-ref3"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>SHOYAB</surname><given-names> M. </given-names></name>,<etal>et al</etal>. (<year>1979</year>)<article-title>CAFFEINE INHIBITS THE BINDING OF DIMETHYLBENZ(A)ANTHRACENE TO MURINE EPIDERMAL CELLS DNA IN CULTURE</article-title><source>. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS</source><volume> 196</volume>,<fpage> 307</fpage>-<lpage>310</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1016/0003-9861(79)90582-4</pub-id></mixed-citation></ref><ref id="scirp.47311-ref4"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>TRAGANOS</surname><given-names> F.</given-names></name>,<name name-style="western"><surname> KAMISKA-EDDY</surname><given-names> B. </given-names></name>,<name name-style="western"><surname> DARZYNKIEWICZ</surname><given-names> Z. </given-names></name>,<etal>et al</etal>. (<year>1991</year>)<article-title>CAFFEINE REVERSES THE CYTOTOXIC AND CELL KINETIC EFFECTS OF NOVANTRONE(MITOXANTRONE)</article-title><source>. CELL PROLIFERATION</source><volume> 24</volume>,<fpage> 305</fpage>-<lpage>319</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1111/J.1365-2184.1991.TB01159.X</pub-id></mixed-citation></ref><ref id="scirp.47311-ref5"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>TRAGANOS</surname><given-names> F.</given-names></name>,<name name-style="western"><surname> KAPUCINSKI</surname><given-names> J.</given-names></name>,<name name-style="western"><surname> DARZYNKIEWICZ</surname><given-names> Z. </given-names></name>,<etal>et al</etal>. (1991)<article-title>CAFFEINE MODULATES THE EFFECTS OF DNA-INTERCALATING DRUGS IN VITRO: A FLOW CYTOMETRIC AND SPECTROPHOTOMETRIC ANALYSIS OF CAFFEINE INTERACTION WITH NOVANTRONE, DOXORUBICIN, ELLIPTICINE, AND THE DOXORUBICIN ANALOGUE AD198</article-title><source>. CANCER RESEARCH</source><volume> 51</volume>,<fpage> 3682</fpage>-<lpage>3689</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.47311-ref6"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>SADZUKA</surname><given-names> Y.</given-names></name>,<name name-style="western"><surname> MACHIZUKI</surname><given-names> E. </given-names></name>,<name name-style="western"><surname> TATINO</surname><given-names> Y. </given-names></name>,<etal>et al</etal>. (<year>1993</year>)<article-title>CAFFEINE MODULATES THE ANTITUMOR ACTIVITY AND TOXIC SIDE EFFECTS OF ADRIAMYCIN</article-title><source>. CANCER SCIENCE</source><volume> 84</volume>,<fpage> 348</fpage>-<lpage>353</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1111/J.1349-7006.1993.TB02877.X</pub-id></mixed-citation></ref><ref id="scirp.47311-ref7"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>SADZUKA</surname><given-names> Y.</given-names></name>,<name name-style="western"><surname> MACHIZUKI</surname><given-names> E. </given-names></name>,<name name-style="western"><surname> TATINO</surname><given-names> Y. </given-names></name>,<etal>et al</etal>. (<year>1995</year>)<article-title>MECHANISM OF CAFFEINE MODULATION OF THE ANTITUMOR ACTIVITY OF ADRIAMYCIN</article-title><source>. TOXICOLOGY LETTERS</source><volume> 75</volume>,<fpage> 39</fpage>-<lpage>49</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1016/0378-4274(94)03154-Y</pub-id></mixed-citation></ref><ref id="scirp.47311-ref8"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>SADZUKA</surname><given-names> Y.</given-names></name>,<name name-style="western"><surname> IWAZAKI</surname><given-names> A.</given-names></name>,<name name-style="western"><surname> MIYAGSHIMA</surname><given-names> Y.</given-names></name>,<name name-style="western"><surname> NOZAWA</surname><given-names> Y. </given-names></name>,<name name-style="western"><surname> HIROTA</surname><given-names> S.J. </given-names></name>,<etal>et al</etal>. (<year>1995</year>)<article-title>CAFFEINE-BIOCHEMICAL MODULATOR OF AXDRIAMYCIN</article-title><source>. CANCER SCIENCE</source><volume> 86</volume>,<fpage> 594</fpage>-<lpage>599</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1111/J.1349-7006.1995.TB02439.X</pub-id></mixed-citation></ref><ref id="scirp.47311-ref9"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>TOMITA</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> TSUCHIYA</surname><given-names> H. </given-names></name>,<name name-style="western"><surname> SASAKI</surname><given-names> T. </given-names></name>,<etal>et al</etal>. (1989)<article-title>TOMITA, K., TSUCHIYA, H. AND SASAKI, T.  THE COMBINATION CIS-PLATIN, ADRIAMYCIN AND CAFFEIN AND WIDE EFFECT ANTITUMOR ACTIVITY</article-title><source>. GAN TO KAGATER RYCHO</source><volume> 16</volume>,<fpage> 576</fpage>-<lpage>584</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.47311-ref10"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>FURUSAWA</surname><given-names> S.</given-names></name>,<name name-style="western"><surname> MALKAWA</surname><given-names> L.</given-names></name>,<name name-style="western"><surname> FUJIMURA</surname><given-names> T.</given-names></name>,<name name-style="western"><surname> TAKAYANAGE</surname><given-names> Y. </given-names></name>,<name name-style="western"><surname> SASAKI</surname><given-names> K. </given-names></name>,<etal>et al</etal>. (1993)<article-title>FURUSAWA, S., MALKAWA, L., FUJIMURA, T., TAKAYANAGE, Y. AND SASAKI, K.  INFLUENCE OF CAFFEINE ON EFFECT OF PIRARUBICIN</article-title><source>. RESEARCH COMMUNICATIONS IN SUBSTANCE ABUSE</source><volume> 14</volume>,<fpage> 179</fpage>-<lpage>192</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.47311-ref11"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>ROBERTS</surname><given-names> J.J. </given-names></name>,<etal>et al</etal>. (1981)<article-title>DAMAGE IN DNA BY CIS-PLATIN</article-title><source>. ADVANCES IN INORGANIC BIOCHEMISTRY</source><volume> 3</volume>,<fpage> 273</fpage>-<lpage>276</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.47311-ref12"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>SHINOMIYA</surname><given-names> N.</given-names></name>,<name name-style="western"><surname> SHINIMIYA</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> WAKAIYAMA</surname><given-names> H.</given-names></name>,<name name-style="western"><surname> KATSURA</surname><given-names> Y. </given-names></name>,<name name-style="western"><surname> ROKUT</surname><given-names>A</given-names></name>,<name name-style="western"><surname> M. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>1994</year>)<article-title>ENHANCEMENT OF CDDP CYTOTOXICITY BY CAFFEINE IS CHARACTERIZED BY APOPTOTIC CELL DEATH</article-title><source>. EXPERIMENTAL CELL RESEARCH</source><volume> 210</volume>,<fpage> 236</fpage>-<lpage>242</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1006/EXCR.1994.1035</pub-id></mixed-citation></ref><ref id="scirp.47311-ref13"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>TOMITA</surname><given-names> A. </given-names></name>,<name name-style="western"><surname> TSUCHIYA</surname><given-names> H. </given-names></name>,<etal>et al</etal>. (1989)<article-title>TOMITA, A. AND TSUCHIYA, H.  CYTOTOXICITY OF CIS-PLATIN IN THE PRESENCE OF CAFFEINE</article-title><source>. CLINICAL THERAPEUTICS</source><volume> 11</volume>,<fpage> 43</fpage>-<lpage>52</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.47311-ref14"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>SADZUKA</surname><given-names> Y.</given-names></name>,<name name-style="western"><surname> EGAWA</surname><given-names> Y.</given-names></name>,<name name-style="western"><surname> SAVANISH</surname><given-names> H.</given-names></name>,<name name-style="western"><surname> MIYAMOTO</surname><given-names> K. </given-names></name>,<name name-style="western"><surname> SONOBE</surname><given-names> T. </given-names></name>,<etal>et al</etal>. (<year>2002</year>)<article-title>EFFECTS OF XANTHINE DERIVATIVES ON THE INFLUX AND EFFLUX OF DOXORUBICIN IN P388 AND DOX-RESISTANT P388 LEUKEMIA CELLS</article-title><source>. TOXICOLOGY LETTERS</source><volume> 135</volume>,<fpage> 137</fpage>-<lpage>144</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1016/S0378-4274(02)00227-8</pub-id></mixed-citation></ref><ref id="scirp.47311-ref15"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>VAN DER BERG</surname><given-names> H.W.</given-names></name>,<name name-style="western"><surname> FAVOL</surname><given-names> H.N.A. </given-names></name>,<name name-style="western"><surname> ROBERTS</surname><given-names> J.J. </given-names></name>,<etal>et al</etal>. (1977)<article-title>VAN DER BERG, H.W., FAVOL, H.N.A. AND ROBERTS, J.J.  CAFFEINE AS INHIBITION OF DNA REPAIN</article-title><source>. JOURNAL OF HEMATOLOGY &amp; ONCOLOGY</source><volume> 7</volume>,<fpage> 349</fpage>-<lpage>373</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.47311-ref16"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>ROTHWELL</surname><given-names> A. </given-names></name>,<etal>et al</etal>. (<year>1974</year>)<article-title>DOSE-RELATED INHIBITION OF CHEMICAL CARCINOGENESIS IN MOUSE SKIN BY CAFFEINE</article-title><source>. NATURE</source><volume> 252</volume>,<fpage> 69</fpage>-<lpage>70</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1038/252069A0</pub-id></mixed-citation></ref><ref id="scirp.47311-ref17"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>BEAULAC-BAILLARGEON</surname><given-names> L. </given-names></name>,<name name-style="western"><surname> DESROSIERS</surname><given-names> C. </given-names></name>,<etal>et al</etal>. (<year>1987</year>)<article-title>CAFFEINE-CIGARETTE INTERACTION ON FETAL GROWTH</article-title><source>. AMERICAN JOURNAL OF OBSTETRICS &amp; GYNECOLOGY</source><volume> 157</volume>,<fpage> 1236</fpage>-<lpage>1240</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1016/S0002-9378(87)80301-0</pub-id></mixed-citation></ref><ref id="scirp.47311-ref18"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>GAUDIN</surname><given-names> D. </given-names></name>,<name name-style="western"><surname> YIELDING</surname><given-names> K.L. </given-names></name>,<etal>et al</etal>. (<year>1969</year>)<article-title>RESPONSE OF A “RESISTANT” PLASMACYTOMA TO ALKYLATING AGENTS AND X-RAY IN COMBINATION WITH THE EXCISION REPAIR INHIBITORS CAFFEINE AND CHLOROQUINE</article-title><source>. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE</source><volume> 131</volume>,<fpage> 1413</fpage>-<lpage>1416</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.3181/00379727-131-34119</pub-id></mixed-citation></ref><ref id="scirp.47311-ref19"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>RAINSKA-GIEZEK</surname><given-names> T. </given-names></name>,<etal>et al</etal>. (1995)<article-title>PARACETAMOL. ROCZNIKI POMORSKIEJ AKADEMII MEDYCZNEJ IM. GEN</article-title><source>. KAROLA SWIERCZEWSKIEGO W SZCZECINIE</source><volume> 41</volume>,<fpage> 69</fpage>-<lpage>84</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.47311-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">EL-BASSIONY, S.F., ABO-HASHIM, N., SIRAG, S.M. AND EL-GHAZALY, Y. (1995) INFLUENCE OF CAFFEINE ON PARACETAMOL INDUCED HEPATOTOXICITY IN RATS. JOURNAL OF ENVIRONMENTAL SCIENCES (MANSOURA, EGYPT), 10, 233-242.</mixed-citation></ref><ref id="scirp.47311-ref21"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>IQBAL</surname><given-names> N.</given-names></name>,<name name-style="western"><surname> AHMAD</surname><given-names> B.</given-names></name>,<name name-style="western"><surname> JANBAZ</surname><given-names> K.H.</given-names></name>,<name name-style="western"><surname> UL HASSAN GIL</surname><given-names></given-names></name>,<name name-style="western"><surname> A. </surname><given-names> SARFEUAZ</given-names></name>,<name name-style="western"><surname> K. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>1995</year>)<article-title>THE EFFECT OF CAFFEINE ON THE PHARMACOKINETICS OF ACETAMINOPHEN IN MAN</article-title><source>. BIOPHARMACEUTICS &amp; DRUG DISPOSITION</source><volume> 16</volume>,<fpage> 481</fpage>-<lpage>487</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1002/BDD.2510160606</pub-id></mixed-citation></ref><ref id="scirp.47311-ref22"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname></surname><given-names>ERSON</given-names></name>,<name name-style="western"><surname> E.D. </surname><given-names> HICKEY</given-names></name>,<name name-style="western"><surname> S. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>1994</year>)<article-title>EFFECTS OF CAFFEINE ON THE METABOLIC AND CATECHOLAMINE RESPONSES TO EXERCISE IN 5 AND 28 DEGREES</article-title><source>. MEDICINE AND SCIENCE IN SPORT AND EXERCISE</source><volume> 26</volume>,<fpage> 453</fpage>-<lpage>458</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1249/00005768-199404000-00009</pub-id></mixed-citation></ref><ref id="scirp.47311-ref23"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>NISHIYAMA</surname><given-names> Y.</given-names></name>,<name name-style="western"><surname> IKEDA</surname><given-names> T.</given-names></name>,<name name-style="western"><surname> TAKAMUTSU</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> KISO</surname><given-names> Y.</given-names></name>,<name name-style="western"><surname> SHIBATA</surname><given-names> H.</given-names></name>,<name name-style="western"><surname> FUSHEKI</surname><given-names> T. </given-names></name>,<name name-style="western"><surname> MORITANE</surname><given-names> T. </given-names></name>,<etal>et al</etal>. (<year>2002</year>)<article-title>INFLUENCE OF CAFFEINE INGESTION ON AUTONOMIC NERVOUS ACTIVITY DURING ENDURANCE EXERCISE IN HUMANS</article-title><source>. EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY</source><volume> 87</volume>,<fpage> 475</fpage>-<lpage>480</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1007/S00421-002-0678-1</pub-id></mixed-citation></ref><ref id="scirp.47311-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">LEBERMAN, H.R., FINE, B.J., KOBRICK, J.L. AND JOHN, J.D.E. (1993) STUDY OF EFFECTS CAFFEINE ON CENTRAL NERVOUS SYSTEM. AGARD CONFERENCE PROCEEDINGS, 533.</mixed-citation></ref><ref id="scirp.47311-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">WURTS, S.W. AND EDGAR, D.M. (2000) CAFFEINE DURING SLEEP DEPRIVATION: SLEEP TENDENCY AND DYNAMICS OF RECOVERY SLEEP IN RATS. PHARMACOLOGY, BIOCHEMISTRY AND BEHAVIOR, 65, 155-162. HTTP://DX.DOI.ORG/10.1016/S0091-3057(99)00173-2</mixed-citation></ref><ref id="scirp.47311-ref26"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>ENGELS</surname><given-names> H.J.</given-names></name>,<name name-style="western"><surname> WIRTH</surname><given-names> J.C.</given-names></name>,<name name-style="western"><surname> CELEK</surname><given-names> S. </given-names></name>,<name name-style="western"><surname> DORSEY</surname><given-names> J.L. </given-names></name>,<etal>et al</etal>. (1999)<article-title>ENGELS, H.J., WIRTH, J.C., CELEK, S. AND DORSEY, J.L.  INFLUENCE OF CAFFEINE ON METABOLIC AND CARDIOVASCULAR FUNCTIONS DURING SUSTAINED LIGHT INTENSITY CYCLING AND AT REST</article-title><source>. INTERNATIONAL JOURNAL OF SPORT NUTRITION</source><volume> 9</volume>,<fpage> 361</fpage>-<lpage>370</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.47311-ref27"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>LIM</surname><given-names> D.Y.</given-names></name>,<name name-style="western"><surname> LEE</surname><given-names> J.M.</given-names></name>,<name name-style="western"><surname> KIM</surname><given-names> W.S.</given-names></name>,<name name-style="western"><surname> KIM</surname><given-names> S.B.</given-names></name>,<name name-style="western"><surname> LEE</surname><given-names> E.H.</given-names></name>,<name name-style="western"><surname> LEE</surname><given-names> J.B. </given-names></name>,<name name-style="western"><surname> KO</surname><given-names> S.T. </given-names></name>,<etal>et al</etal>. (<year>1991</year>)<article-title>STUDIES ON SECRETION OF CATECHOLAMINE EVOKED BY CAFFEINE FROM THE ISOLATED PERFUSED RAT ADRENAL GLAND</article-title><source>. ARCHIVES OF PHARMACAL RESEARCH</source><volume> 14</volume>,<fpage> 55</fpage>-<lpage>67</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1007/BF02857816</pub-id></mixed-citation></ref><ref id="scirp.47311-ref28"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>SU</surname><given-names> J.Y. </given-names></name>,<etal>et al</etal>. (1991)<article-title>INFLUENCE OF CAFFEINE, CA2+, AND MG2+ ON RYANODINE DEPRESSION OF THE TENSION TRANSIENT IN SKINNED MYOCARDIAL FIBERS OF THE RABBIT</article-title><source>. PFLÜGERS ARCHIV: EUROPEAN JOURNAL OF PHYSIOLOGY</source><volume> 421</volume>,<fpage> 1</fpage>-<lpage>6</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.47311-ref29"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>KAGAWA</surname><given-names> Y.</given-names></name>,<name name-style="western"><surname> MAYUMI</surname><given-names> N.</given-names></name>,<name name-style="western"><surname> HIGASHIGAWA</surname><given-names> S.</given-names></name>,<name name-style="western"><surname> KATSUDA</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> KAKITO</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> INAGAKI</surname><given-names> S.</given-names></name>,<name name-style="western"><surname> OHSUGI</surname><given-names> H.</given-names></name>,<name name-style="western"><surname> SUMIDA</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> SAKURAI</surname><given-names> M. </given-names></name>,<name name-style="western"><surname> EDOBASHI</surname><given-names> T. </given-names></name>,<etal>et al</etal>. (1992)<article-title>KAGAWA, Y., MAYUMI, N., HIGASHIGAWA, S., KATSUDA, K., KAKITO, M., INAGAKI, S., OHSUGI, H., SUMIDA, K., SAKURAI, M. AND EDOBASHI, T.  CAFFEINE FACILITATES THE CONVERSION OF ALLOPURINOL TO OXIPURINOL</article-title><source>. MIE MEDICAL JOURNAL</source><volume> 42</volume>,<fpage> 203</fpage>-<lpage>207</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.47311-ref30"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>VALDES</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> SHAYE</surname><given-names> R.</given-names></name>,<name name-style="western"><surname> JOSEPH JR.</surname><given-names> F. </given-names></name>,<name name-style="western"><surname> NAKAMOTO</surname><given-names> T. </given-names></name>,<etal>et al</etal>. (<year>1992</year>)<article-title>THE EFFECTS OF CAFFEINE ON THE MAXILLARY COMPOSITION IN THE NEWBORN RAT</article-title><source>. CALCIFIED TISSUE INTERNATIONAL</source><volume> 50</volume>,<fpage> 165</fpage>-<lpage>168</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1007/BF00298795</pub-id></mixed-citation></ref><ref id="scirp.47311-ref31"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>KRUK</surname><given-names> B.</given-names></name>,<name name-style="western"><surname> CHMURA</surname><given-names> J.</given-names></name>,<name name-style="western"><surname> KRZEMINSKI</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> ZIEMBA</surname><given-names> A.W.</given-names></name>,<name name-style="western"><surname> NAZAR</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> PEKKARINEN</surname><given-names> H. </given-names></name>,<name name-style="western"><surname> KACIUBA-USCILKO</surname><given-names> H. </given-names></name>,<etal>et al</etal>. (<year>2001</year>)<article-title>INFLUENCE OF CAFFEINE, COLD AND EXERCISE ON MULTIPLE CHOICE REACTION TIME</article-title><source>. PSYCHOPHARMACOLOGY</source><volume> 157</volume>,<fpage> 197</fpage>-<lpage>201</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1007/S002130100787</pub-id></mixed-citation></ref><ref id="scirp.47311-ref32"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>ITO</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> LIM</surname><given-names> S.</given-names></name>,<name name-style="western"><surname> CARAMORI</surname><given-names> G.</given-names></name>,<name name-style="western"><surname> COSIIO</surname><given-names> B.</given-names></name>,<name name-style="western"><surname> CHUNG</surname><given-names> K.F.</given-names></name>,<name name-style="western"><surname> ADCOCK</surname><given-names> T.M. </given-names></name>,<name name-style="western"><surname> BARNES</surname><given-names> P.J. </given-names></name>,<etal>et al</etal>. (2002)<article-title>ITO, K., LIM, S., CARAMORI, G., COSIIO, B., CHUNG, K.F., ADCOCK, T.M. AND BARNES, P.J.  A MOLECULAR MECHANISM OF ACTION OF THEOPHYLLINE: INDUCTION OF HISTONE DEACETYLASE ACTIVITY TO DECREASE INFLAMMATORY GENE EXPRESSION</article-title><source>. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA</source><volume> 99</volume>,<fpage> 8921</fpage>-<lpage>8926</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.47311-ref33"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>SAGARA</surname><given-names> H.</given-names></name>,<name name-style="western"><surname> MAKINO</surname><given-names> S.</given-names></name>,<name name-style="western"><surname> CHIBANA</surname><given-names> N.</given-names></name>,<name name-style="western"><surname> OTA</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> HOLGATE</surname><given-names> S.T.</given-names></name>,<name name-style="western"><surname> CHURCH</surname><given-names> M.K. </given-names></name>,<name name-style="western"><surname> FUKUDA</surname><given-names> T. </given-names></name>,<etal>et al</etal>. (<year>2001</year>)<article-title>THEOPHYLINE AT THERAPEUTIC CONCENTRATIONS INHIBITS NF-ΚB ACTIVATION IN HUMAN LUNG MAST CELLS</article-title><source>. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY</source><volume> 124</volume>,<fpage> 371</fpage>-<lpage>375</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1159/000053761</pub-id></mixed-citation></ref><ref id="scirp.47311-ref34"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>LOUIS</surname><given-names> R.</given-names></name>,<name name-style="western"><surname> BETTIOL</surname><given-names> J.</given-names></name>,<name name-style="western"><surname> CATALDO</surname><given-names> D.</given-names></name>,<name name-style="western"><surname> SELE</surname><given-names> J.</given-names></name>,<name name-style="western"><surname> HENQUET</surname><given-names> M. </given-names></name>,<name name-style="western"><surname> RADEMECKER</surname><given-names> M. </given-names></name>,<etal>et al</etal>. (<year>2000</year>)<article-title>EFFECT OF A 4-WEEK TREATMENT WITH THEOPHYLLINE ON SPUTUM EOSINOPHILIA AND SPUTUM EOSINOPHIL CHEMOTACTIC ACTIVITY IN STEROID-NAIVE ASTHMATICS</article-title><source>. CLINICAL &amp; EXPERIMENTAL ALLERGY</source><volume> 30</volume>,<fpage> 1151</fpage>-<lpage>1160</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1046/J.1365-2222.2000.00867.X</pub-id></mixed-citation></ref><ref id="scirp.47311-ref35"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>TAKEUCHI</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> HAYAKAWA</surname><given-names> A.</given-names></name>,<name name-style="western"><surname> TAKAGI</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> HIRAMATSU</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> SHIMIZU</surname><given-names> Y.</given-names></name>,<name name-style="western"><surname> MATSUMOTO</surname><given-names> S.</given-names></name>,<name name-style="western"><surname> HIRAMATSU</surname><given-names> T.</given-names></name>,<name name-style="western"><surname> ITO</surname><given-names> Y.</given-names></name>,<name name-style="western"><surname> KUME</surname><given-names> H.</given-names></name>,<name name-style="western"><surname> SUZUKI</surname><given-names> R. </given-names></name>,<name name-style="western"><surname> YAMAKI</surname><given-names> K. </given-names></name>,<etal>et al</etal>. (<year>1999</year>)<article-title>THEOPHYLLINE INDUCES APOPTOSIS OF THE IL-3 ACTIVATED EOSINOPHILS OF PATIENTS WITH BRONCHIAL ASTHMA</article-title><source>. APOPTOSIS</source><volume> 4</volume>,<fpage> 461</fpage>-<lpage>468</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1023/A:1009656527168</pub-id></mixed-citation></ref><ref id="scirp.47311-ref36"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>LIN</surname><given-names> Z.T.</given-names></name>,<name name-style="western"><surname> HUANG</surname><given-names> H.L.</given-names></name>,<name name-style="western"><surname> ZHAO</surname><given-names> L.N.</given-names></name>,<name name-style="western"><surname> YU</surname><given-names> Q.S. </given-names></name>,<name name-style="western"><surname> ZHONG</surname><given-names> N.S. </given-names></name>,<etal>et al</etal>. (1998)<article-title>LIN, Z.T., HUANG, H.L., ZHAO, L.N., YU, Q.S. AND ZHONG, N.S.  INHIBITED OF THEOPHYLLINE ON FACTOR (PAF) IN ASTHMA</article-title><source>. ZHONGGUO YAOYAU-LIXUE TONGBAO</source><volume> 14</volume>,<fpage> 30</fpage>-<lpage>32</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.47311-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">BLAKE, K. (1999) THEOPHYLLINE. IN: MURPHY, S. AND KELLY, H.W., EDS., PEDIATRIC ASTHMA, MARCELDEKKER, NEW YORK, 363-431.</mixed-citation></ref><ref id="scirp.47311-ref38"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>ICHIYAMA</surname><given-names> T.</given-names></name>,<name name-style="western"><surname> HASEGAWA</surname><given-names> S.</given-names></name>,<name name-style="western"><surname> MATSUBARA</surname><given-names> T.</given-names></name>,<name name-style="western"><surname> HAYASHI</surname><given-names> T. </given-names></name>,<name name-style="western"><surname> FURUKAWA</surname><given-names> S. </given-names></name>,<etal>et al</etal>. (2001)<article-title>ICHIYAMA, T., HASEGAWA, S., MATSUBARA, T., HAYASHI, T. AND FURUKAWA, S.  THEOPHYLLINE INHIBITS NF-KAPPA B ACTIVATION AND I KAPPA B ALPHA DEGRADATION IN HUMAN PULMONARY EPITHELIAL CELLS</article-title><source>. NAUNUM-SCHMIEDEBERG’S ARCHIEVES OF PHARMACOLOGY</source><volume> 364</volume>,<fpage> 558</fpage>-<lpage>561</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.47311-ref39"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>ALHOMIDA</surname><given-names> A.S. </given-names></name>,<etal>et al</etal>. (<year>2001</year>)<article-title>ORAL THEOPHYLLINE CHANGES RENAL CARNITINE PALMITOYLTRANSFERASE ACTIVITY IN RATS</article-title><source>. ARCHIVES OF MEDICAL RESEARCH</source><volume> 32</volume>,<fpage> 394</fpage>-<lpage>399</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1016/S0188-4409(01)00299-5</pub-id></mixed-citation></ref><ref id="scirp.47311-ref40"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>ALHOMIDA</surname><given-names> A.S. </given-names></name>,<etal>et al</etal>. (<year>2001</year>)<article-title>EVALUATION OF THEOPHYLLINE-STIMULATED CHANGES IN CARNITINE PALMITOYLTRANSFERASE ACTIVITY IN SKELETAL MUSCLE AND LIVER OF RATS</article-title><source>. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY</source><volume> 16</volume>,<fpage> 177</fpage>-<lpage>183</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1080/14756360109162367</pub-id></mixed-citation></ref><ref id="scirp.47311-ref41"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>ALHOMIDA</surname><given-names> A.S. </given-names></name>,<etal>et al</etal>. (1998)<article-title>EVALUATION OF THE IMPACT OF THEOPHYLLINE TREATMENT ON CARNITINE ACETYLTRANSFERASE ACTIVITY IN RAT KIDNEY</article-title><source>. IN VIVO</source><volume> 12</volume>,<fpage> 553</fpage>-<lpage>558</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.47311-ref42"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>ALHOMIDA</surname><given-names> A.S. </given-names></name>,<etal>et al</etal>. (1999)<article-title>STUDY OF THEOPHYLLINE ON THE LEVEL OF CARNITINE IN THE CARDIAC TISSUES OF RATS</article-title><source>. JOURNAL OF BIOCHEMISTRY MOLECULAR BIOLOGY AND BIOPHYSICS</source><volume> 2</volume>,<fpage> 273</fpage>-<lpage>280</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.47311-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">MANDAL, M. AND PODAR, M.K. (2001) BRAIN REGIONAL ADENYLATE CYCLASE ACTIVITY: EFFECT OF THEOPHYLLINE UNDER NON-TOLERANT AND TOLERANT CONDITIONS. BIOGENIC AMINES, 16, 251-268.</mixed-citation></ref><ref id="scirp.47311-ref44"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>OKUMURA</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> KAI</surname><given-names> H.</given-names></name>,<name name-style="western"><surname> SHINOZAWA</surname><given-names> S.</given-names></name>,<name name-style="western"><surname> ISOHAMA</surname><given-names> Y.</given-names></name>,<name name-style="western"><surname> TAKAHAMA</surname><given-names> K. </given-names></name>,<name name-style="western"><surname> MIYATA</surname><given-names> T. </given-names></name>,<etal>et al</etal>. (1997)<article-title>OKUMURA, M., KAI, H., SHINOZAWA, S., ISOHAMA, Y., TAKAHAMA, K. AND MIYATA, T.  EFFECTS OF XANTHINE DERIVATIVES ON PHOSPHATIDYLCHOLINE SECRETION IN RAT TYPE II PNEUMOCYTES IN THE PRESENCE OF ACTIVATED EOSINOPHILS</article-title><source>. JAPANESE JOURNAL OF PHARMACOLOGY</source><volume> 75</volume>,<fpage> 425</fpage>-<lpage>432</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.47311-ref45"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>FAANG</surname><given-names> N. </given-names></name>,<name name-style="western"><surname> NUTTALL</surname><given-names> F.Q. </given-names></name>,<etal>et al</etal>. (1997)<article-title>FAANG, N. AND NUTTALL, F.Q.  THE EFFECT OF CAFFEINE AND CAFFEINE ANALOGS ON RAT LIVER PHOSPHORYLASE A ACTIVITY</article-title><source>. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS</source><volume> 280</volume>,<fpage> 1312</fpage>-<lpage>1318</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.47311-ref46"><label>46</label><mixed-citation publication-type="other" xlink:type="simple">BANDYOPADHYAY, B.C. AND PODDAR, M.K. (1997) THEOPHYLLINE-INDUCED CHANGES IN MAMMALIAN ADENOSINE DEAMINASE ACTIVITY AND CORTICOSTERONE STATUS: POSSIBLE RELATION TO IMMUNE RESPONSE. METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 19, 181-184.</mixed-citation></ref><ref id="scirp.47311-ref47"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>ONER</surname><given-names> P.</given-names></name>,<name name-style="western"><surname> GURDOL</surname><given-names> F.</given-names></name>,<name name-style="western"><surname> ONER-IYIDON</surname><given-names> Y.</given-names></name>,<name name-style="western"><surname> KOLANCI</surname><given-names> C. </given-names></name>,<name name-style="western"><surname> BUYUKOZTURK</surname><given-names> S. </given-names></name>,<etal>et al</etal>. (<year>1999</year>)<article-title>EVALUATION OF THE EFFECT OF LOW-DOSE ORAL THEOPHYLLINE THERAPY ON SOME BONE TURNOVER MARKERS AND SERUM PROLIDASE I ACTIVITY IN MILD ASTHMATICS</article-title><source>. PHARMACOLOGICAL RESEARCH</source><volume> 40</volume>,<fpage> 189</fpage>-<lpage>193</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1006/PHRS.1999.0486</pub-id></mixed-citation></ref><ref id="scirp.47311-ref48"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>KAWAKAMI</surname><given-names> E.</given-names></name>,<name name-style="western"><surname> ARAI</surname><given-names> T. </given-names></name>,<name name-style="western"><surname> NAKAMURA</surname><given-names> U. </given-names></name>,<etal>et al</etal>. (<year>1999</year>)<article-title>EFFECTS OF MEDIUM CONTAINING HEPARIN AND THEOPHYLLINE ON CAPACITATION AND METABOLIC ENZYME ACTIVITIES OF EJACULATED SPERMATOZOA FROM DOGS WITH ASTHENOZOOSPERMIA</article-title><source>. ANIMAL REPRODUCTION SCIENCE</source><volume> 54</volume>,<fpage> 251</fpage>-<lpage>259</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1016/S0378-4320(98)00158-4</pub-id></mixed-citation></ref><ref id="scirp.47311-ref49"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>SAKO</surname><given-names> J.</given-names></name>,<name name-style="western"><surname> HORI</surname><given-names> S. </given-names></name>,<name name-style="western"><surname> KAWAMURA</surname><given-names> M. </given-names></name>,<etal>et al</etal>. (1998)<article-title>SAKO, J., HORI, S. AND KAWAMURA, M.  EFFECT OF THEOPHYLLINE, CAFFEINE AND DIMETHYLXANTHINES ON ENDOGENOUS GLUCOCORTICOID LEVELS IN MICE. A POSSIBLE MECHANISM OF ANTI-INFLAMMATORY ACTIVITY OF THEOPHYLLINE</article-title><source>. PHARMACY AND PHARMACOLOGY COMMUNICATIONS</source><volume> 4</volume>,<fpage> 499</fpage>-<lpage>501</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.47311-ref50"><label>50</label><mixed-citation publication-type="other" xlink:type="simple">EBISUZAKI, Y., BOYLE, P.D. AND SMITH, J.A. (1997) METHYLXANTHINES. I. ANHYDROUS THEOPHYLLINE. ACTA CRYSTALLOGRAPHICA SECTION C, CRYSTAL STRUCTURE COMMUNICATIONS, 53, 777-779. HTTP://DX.DOI.ORG/10.1107/S0108270197001960</mixed-citation></ref><ref id="scirp.47311-ref51"><label>51</label><mixed-citation publication-type="other" xlink:type="simple">NAKAO, S., FUJI, S., SAKAKI, T. AND TOMITA, K. (1977) CRYSTAL AND MOLECULAR-STRUCTURE OF 2-1 MOLECULAR-COMPLEX OF THEOPHYLLINE WITH PHENOBARBITAL. ACTA CRYSTALLOGRAPHICA SECTION C, CRYSTAL STRUCTURE COMMUNICATIONS, 33, 1373-1376.</mixed-citation></ref><ref id="scirp.47311-ref52"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DEL BARTOLO RUENIS</surname><given-names> A.P.</given-names></name>,<name name-style="western"><surname> ROSALEN</surname><given-names> P.L.</given-names></name>,<name name-style="western"><surname> VOLPATO</surname><given-names> C.M. </given-names></name>,<name name-style="western"><surname> GROPO</surname><given-names> F.C. </given-names></name>,<etal>et al</etal>. (<year>2000</year>)<article-title>EFFECTS OF CAFFEINE AND THEOPHYLLINE ON THE DEVELOPMENT OF DENTAL CARIES IN RATS</article-title><source>. BIOLOGICAL &amp; PHARMACEUTICAL BULLETIN</source><volume> 23</volume>,<fpage> 339</fpage>-<lpage>343</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1248/BPB.23.339</pub-id></mixed-citation></ref><ref id="scirp.47311-ref53"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>SADZUKA</surname><given-names> Y.</given-names></name>,<name name-style="western"><surname> IWAZAKI</surname><given-names> A. </given-names></name>,<name name-style="western"><surname> HIROTA</surname><given-names> S. </given-names></name>,<etal>et al</etal>. (1998)<article-title>SADZUKA, Y., IWAZAKI, A. AND HIROTA, S.  EFFECTS OF METHYLXANTHINE DERIVATIVES ON ANTITUMOR ACTIVITY AND TOXIC SIDE EFFECT OF ADRIAMYCIN INDUCED BY INHIBITION OF DNA BIOSYNTHESIS</article-title><source>. YAKUGAKU ZASSHI</source><volume> 118</volume>,<fpage> 179</fpage>-<lpage>187</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.47311-ref54"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>KAKUYAMA</surname><given-names> A. </given-names></name>,<name name-style="western"><surname> SADZUKA</surname><given-names> Y. </given-names></name>,<etal>et al</etal>. (<year>2001</year>)<article-title>EFFECT OF METHYLXANTHINE DERIVATIVES ON DOXORUBICIN TRANSPORT AND ANTITUMOR ACTIVITY</article-title><source>. CURRENT DRUG METABOLISM</source><volume> 2</volume>,<fpage> 379</fpage>-<lpage>395</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.2174/1389200013338270</pub-id></mixed-citation></ref><ref id="scirp.47311-ref55"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>NOMURA</surname><given-names> T. </given-names></name>,<etal>et al</etal>. (1983)<article-title>COMPARATIVE INHIBITING EFFECTS OF METHYLXANTHINES ON URETHAN-INDUCED TUMORS, MALFORMATIONS, AND PRESUMED SOMATIC MUTATIONS IN MICE</article-title><source>. CANCER RESEARCH</source><volume> 43</volume>,<fpage> 1342</fpage>-<lpage>1346</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.47311-ref56"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>HOSSEINZADEH</surname><given-names> H. </given-names></name>,<name name-style="western"><surname> DEGHAN</surname><given-names> R. </given-names></name>,<etal>et al</etal>. (1999)<article-title>HOSSEINZADEH, H. AND DEGHAN, R.  ANTI-INFLAMMATORYNACTIVITY OF PURINE ALKALOIDS</article-title><source>. PHARMACEUTICAL AND PHARMACOLOGICAL LETTERS</source><volume> 9</volume>,<fpage> 18</fpage>-<lpage>19</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.47311-ref57"><label>57</label><mixed-citation publication-type="other" xlink:type="simple">POLLARD, I., LOCQUET, O., ODETTE, S., SOLVAR, A. AND MAGRE, S. (2001) EFFECTS OF CAFFEINE AND ITS REACTIVE METABOLITES THEOPHYLLINE AND THEOBROMINE ON THE DIFFERENTIATING TESTIS. REPRODUCTION, FERTILITY AND DEVELOPMENT, 13, 435-441. HTTP://DX.DOI.ORG/10.1071/RD01018</mixed-citation></ref><ref id="scirp.47311-ref58"><label>58</label><mixed-citation publication-type="other" xlink:type="simple">RETTIE, E.A. AND DIETER, H.D. (2000) CAN CAFFEINE METABOLISM BE USED AS AN IN-VIVO PROBE FOR HUMAN FLAVIN-CONTAINING MONOOXYGENASE ACTIVITY? PHARMACOGENETICS, 10, 275-277. HTTP://DX.DOI.ORG/10.1097/00008571-200004000-00010</mixed-citation></ref><ref id="scirp.47311-ref59"><label>59</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>KURIBARA</surname><given-names> H.</given-names></name>,<name name-style="western"><surname> ASAHI</surname><given-names> T. </given-names></name>,<name name-style="western"><surname> TADOKORO</surname><given-names> S. </given-names></name>,<etal>et al</etal>. (<year>1992</year>)<article-title>BEHAVIORAL EVALUATION OF PSYCHO-PHARMACOLOGICAL AND PSYCHOTOXIC ACTIONS OF METHYLXANTHINES BY AMBULATORY ACTIVITY AND DISCRETE AVOIDANCE IN MICE</article-title><source>. JOURNAL OF TOXICOLOGICAL SCIENCES</source><volume> 17</volume>,<fpage> 81</fpage>-<lpage>90</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.2131/JTS.17.81</pub-id></mixed-citation></ref><ref id="scirp.47311-ref60"><label>60</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>SHEFTER</surname><given-names> E. </given-names></name>,<etal>et al</etal>. (<year>1968</year>)<article-title>STRUCTURAL STUDIES ON COMPLEXES II. CRYSTAL AND MOLECULAR STRUCTURE OF A 1:1 CAFFEINE AND 5-CHLOROSALICYCLIC ACID COMPLEX</article-title><source>. JOURNAL OF PHARMACEUTICAL SCIENCES</source><volume> 57</volume>,<fpage> 1163</fpage>-<lpage>1168</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1002/JPS.2600570715</pub-id></mixed-citation></ref><ref id="scirp.47311-ref61"><label>61</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>CRAVEN</surname><given-names> B.M. </given-names></name>,<name name-style="western"><surname> GARTL</surname><given-names></given-names></name>,<name name-style="western"><surname> G.L. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>1974</year>)<article-title>THE 2:1 CRYSTAL COMPLEX OF 5,5-DIETHYLBARBITURIC ACID (BARBITAL) AND CAFFEINE</article-title><source>. ACTA CRYSTALLOGRAPHICA SECTION B</source><volume> 30</volume>,<fpage> 1191</fpage>-<lpage>1195</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1107/S0567740874004559</pub-id></mixed-citation></ref><ref id="scirp.47311-ref62"><label>62</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>MERCER</surname><given-names> A. </given-names></name>,<name name-style="western"><surname> TROTTER</surname><given-names> J. </given-names></name>,<etal>et al</etal>. (<year>1978</year>)<article-title>CRYSTAL AND MOLECULAR STRUCTURE OF 1,3,7-TRIMETHYL-2,6-PURINEDIONE HYDROCHLORIDE DIHYDRATE (CAFFEINE HYDROCHLORIDE DIHYDRATE)</article-title><source>. ACTA CRYSTALLOGRAPHICA SECTION B</source><volume> 34</volume>,<fpage> 450</fpage>-<lpage>453</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1107/S0567740878003337</pub-id></mixed-citation></ref><ref id="scirp.47311-ref63"><label>63</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>CINGI</surname><given-names> M.B.</given-names></name>,<name name-style="western"><surname> VILLA</surname><given-names> A.C.</given-names></name>,<name name-style="western"><surname> MANFREDOTTI</surname><given-names> A.G. </given-names></name>,<name name-style="western"><surname> GUASTINI</surname><given-names> C. </given-names></name>,<etal>et al</etal>. (1972)<article-title>CINGI, M.B., VILLA, A.C., MANFREDOTTI, A.G. AND GUASTINI, C.  CRYSTAL STRUCTURE OF CAFFEINE-HYDROCHLORIDE DIHYDRATE</article-title><source>. CRYSTAL STRUCTURE COMMUNICATIONS</source><volume> 1</volume>,<fpage> 363</fpage>-<lpage>365</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.47311-ref64"><label>64</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>BONDOLI</surname><given-names> G.</given-names></name>,<name name-style="western"><surname> BIAGINI</surname><given-names> M.C.</given-names></name>,<name name-style="western"><surname> CLEMENTE</surname><given-names> D.A. </given-names></name>,<name name-style="western"><surname> RIZZARDI</surname><given-names> G. </given-names></name>,<etal>et al</etal>. (<year>1976</year>)<article-title>PREPARATION, CRYSTAL AND MOLECULAR STRUCTURE OF AQUADICHLOROCAFFEINECOPPER(II)</article-title><source>. INORGANICA CHIMICA ACTA</source><volume> 20</volume>,<fpage> 71</fpage>-<lpage>78</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1016/S0020-1693(00)94093-3</pub-id></mixed-citation></ref><ref id="scirp.47311-ref65"><label>65</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>KOMAN</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> MELNIK</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> MONCOL</surname><given-names> J. </given-names></name>,<name name-style="western"><surname> GLOWIAK</surname><given-names> T. </given-names></name>,<etal>et al</etal>. (<year>2000</year>)<article-title>CAFFEINE IN COPPER(II) COMPLEXES: CRYSTAL AND MOLECULAR STRUCTURE OF DI(CAFFEINE)TETRAKIS(NAPROXENATO) DICOPPER(II)</article-title><source>. INORGANIC CHEMISTRY COMMUNICATIONS</source><volume> 3</volume>,<fpage> 489</fpage>-<lpage>492</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1016/S1387-7003(00)00122-2</pub-id></mixed-citation></ref><ref id="scirp.47311-ref66"><label>66</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>VALACH</surname><given-names> F.</given-names></name>,<name name-style="western"><surname> MELNIK</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> BERNARDINELLI</surname><given-names> G. </given-names></name>,<name name-style="western"><surname> FROM</surname><given-names> K.M. </given-names></name>,<etal>et al</etal>. (<year>2006</year>)<article-title>A STRUCTURAL STUDY OF COPPER(II) CARBOXYLATES: CRYSTAL STRUCTURE AND PHYSICAL CHARACTERISATION OF [CU2(2-BROMOPROPANOATO)4(CAFFEINE)2]</article-title><source>. JOURNAL OF CHEMICAL CRYSTALLOGRAPHY</source><volume> 36</volume>,<fpage> 571</fpage>-<lpage>580</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1007/S10870-006-9102-8</pub-id></mixed-citation></ref><ref id="scirp.47311-ref67"><label>67</label><mixed-citation publication-type="other" xlink:type="simple">SEGLA, P., MIKLOS, D. AND MELNIK, M. (2010) STRUCTURES, PHYSICO-CHEMICAL PROPERTIES AND BIOLOGICAL ACTIVITIES OF COPPER(II) PYRIDINECARBOXYLATES. NOVA SCIENCE PUBLISHERS, INC., NEW YORK, 1-82.</mixed-citation></ref><ref id="scirp.47311-ref68"><label>68</label><mixed-citation publication-type="other" xlink:type="simple">DUDOVÁ, B., HUDECOVÁ, D., POKORNY, R., MIKULÁSOVÁ, M., PALICOVÁ, M., SEGL'A, P. AND MELNÍK, M. (2001) COPPER COMPLEXES WITH BIOACTIVE LIGANDS. PART I-ANTIMICROBIAL ACTIVITY, FOLIA MICROBIOLOGICA, 46, 379-384. HTTP://DX.DOI.ORG/10.1007/BF02814425</mixed-citation></ref><ref id="scirp.47311-ref69"><label>69</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DUDOVA</surname><given-names> B.</given-names></name>,<name name-style="western"><surname> HUDECOVA</surname><given-names> D.</given-names></name>,<name name-style="western"><surname> POKORNY</surname><given-names> R.</given-names></name>,<name name-style="western"><surname> MICKOVA</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> PALICOVA</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> SEGLA</surname><given-names> P. </given-names></name>,<name name-style="western"><surname> MELNIK</surname><given-names> M. </given-names></name>,<etal>et al</etal>. (<year>2002</year>)<article-title>COPPER COMPLEXES WITH BIOACTIVE LIGANDS—PART II—ANTIFUNGAL ACTIVITY</article-title><source>. FOLIA MICROBIOLOGICA</source><volume> 47</volume>,<fpage> 225</fpage>-<lpage>229</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1007/BF02817642</pub-id></mixed-citation></ref></ref-list></back></article>